Shared decision making for the initiation and continuation of dialysis: a proposal from the Japanese Society for Dialysis Therapy

Author:

Okada Kazuyoshi,Tsuchiya Ken,Sakai Ken,Kuragano Takahiro,Uchida Akiko,Tsuruya Kazuhiko,Tomo Tadashi,Hamada Chieko,Fukagawa Masafumi,Kawaguchi Yoshindo,Watanabe Yuzo,Aita Kaoruko,Ogawa Yoshitatsu,Uchino Junji,Okada Hirokazu,Koda Yutaka,Komatsu Yasuhiro,Sato Hisamitsu,Hattori Motoshi,Baba Toru,Matsumura Mamiko,Miura Hisayuki,Minakuchi Jun,Nakamoto Hidetomo,Okada Kazuyoshi,Tsuchiya Ken,Sakai Ken,Kuragano Takahiro,Uchida Akiko,Tsuruya Kazuhiko,Tomo Tadashi,Hamada Chieko,Fukagawa Masafumi,Kawaguchi Yoshindo,Watanabe Yuzo,Aita Kaoruko,Ogawa Yoshitatsu,Uchino Junji,Okada Hirokazu,Koda Yutaka,Komatsu Yasuhiro,Sato Hisamitsu,Hattori Motoshi,Baba Toru,Matsumura Mamiko,Miura Hisayuki,Minakuchi Jun,Nakamoto Hidetomo,

Abstract

Abstract Background In Japan, forgoing life-sustaining treatment to respect the will of patients at the terminal stage is not stipulated by law. According to the Guidelines for the Decision-Making Process in Terminal-Stage Healthcare published by the Ministry of Health, Labor and Welfare in 2007, the Japanese Society for Dialysis Therapy (JSDT) developed a proposal that was limited to patients at the terminal stage and did not explicitly cover patients with dementia. This proposal for the shared decision-making process regarding the initiation and continuation of maintenance hemodialysis was published in 2014. Methods and results In response to changes in social conditions, the JSDT revised the proposal in 2020 to provide guidance for the process by which the healthcare team can provide the best healthcare management and care with respect to the patient's will through advance care planning and shared decision making. For all patients with end-stage kidney disease, including those at the nonterminal stage and those with dementia, the decision-making process includes conservative kidney management. Conclusions The proposal is based on consensus rather than evidence-based clinical practice guidelines. The healthcare team is therefore not guaranteed to be legally exempt if the patient dies after the policies in the proposal are implemented and must respond appropriately at the discretion of each institution.

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Urology,Nephrology

Reference49 articles.

1. Ministry of Health, Labour and Welfare. Guidelines for the decision-making process in terminal-stage healthcare. http://www.mhlw.go.jp/shingi/2007/05/dl/s0521-11a.pdf. Accessed 12 May 2021.

2. Ministry of Health, Labour and Welfare. Guidelines for the decision-making process in end-of-life healthcare. https://www.mhlw.go.jp/file/04-Houdouhappyou-10802000-Iseikyoku-Shidouka/0000079906.pdf. Accessed 12 May 2021.

3. Ministry of Health, Labour and Welfare. Guidelines for the decision-making process in end-of-life healthcare management and care. https://www.mhlw.go.jp/file/04-Houdouhappyou-10802000-Iseikyoku-Shidouka/0000197701.pdf. Accessed 12 May 2021.

4. Japanese Society for Dialysis Therapy. Proposal for the shared decision-making process regarding initiation and continuation of maintenance hemodialysis. J Jpn Soc Dial Ther. 2014;47:269–85.

5. Okada K, Japanese Society for Dialysis Therapy. Proposal for the shared decision-making process for initiation and continuation of maintenance hemodialysis: survey after introduction. J Jpn Ass Dial Physician. 2019;34:1106.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3